US 8110192
Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency
granted A61KA61K2039/505A61K2039/605
Quick answer
US patent 8110192 (Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Feb 07 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61K2039/605, A61K39/12, A61K39/21